D-0033-2018 Class III Terminated
FDA drug recall D-0033-2018 was initiated by AbbVie Inc. on Sep 8, 2017 and is designated Class III. Reason for recall: Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions. The recall status is terminated (terminated Apr 23, 2018). Affected quantity: 520 pumps.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 1, 2017
- Initiation Date
- Sep 8, 2017
- Termination Date
- Apr 23, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 520 pumps
Product description
AndroGel (testosterone gel) 1.62%, 88 gm metered-dose pump, 20.25 mg of testosterone per pump actuation, 60 metered pump actuations, Rx Only, Marketed by: AbbVie Inc., North Chicago, IL 60064 USA. NDC: 0051-8462-33
Reason for recall
Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions.
Distribution pattern
AZ
Code information
Lot: 91122, EXP. 01/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0033-2018
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026